Sağlık Bilimlerinde İleri Araştırmalar Dergisi

GÖNDERBİLGİ
EnglishTürkçe

Derleme


DOI :10.26650/JARHS2020-726533   IUP :10.26650/JARHS2020-726533    Tam Metin (PDF)

Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu

Gözde Öztan, Halim İşsever

İnsandan insana bulaşan ve atipik pnömoni salgınıyla ilişkili yeni bir şiddetli akut solunum sendromu koronavirüs 2 (SARS-CoV-2), Çin'in Wuhan şehrinde ortaya çıkmıştır. Yarasalar, SARS-CoV, MERS-CoV ve COVID-19 için birincil rezervuar olsa da, SARS-CoV’nin, Çin'deki misk kedilerinden, MERS-CoV’nin, Orta Doğu'daki develerden, COVID-19’un yarasadan insana pangolin (pullu karıncayiyen) aracılığıyla bulaşmış olabileceği ortaya çıkmıştır. Epidemiyolojik salgınlara yol açan koronavirüs ailesine ve betakoronavirüs cinsine ait üç insan koronavirüsü (SARS-CoV, MERS-CoV ve SARS-CoV-2) yaklaşık 32 Kb uzunluğunda pozitif anlamlı tek iplikli RNA'sı olan zarflı virüslerden olup enfeksiyonla ilişkili yüksek mortalite oranlarıyla proenflamatuar yanıtların patogenezinde rol oynamaktadırlar. 2019-nCoV genomu, yarasa SARS benzeri CoVZXC21 ile % 89 ve insan SARS-CoV'siyle % 82 nükleotid benzerliğine sahiptir. Orf1a/b, spike, zarf, membran ve nükleoproteinlerinin filogenetik ağaçları yarasa, misk kedisi ve insan SARS koronavirüslerininkiyle yakından ilişkilidir. Anjiyotensin-I dönüştürücü enzim 2 (ACE2), şiddetli akut solunum sendromu koronavirüsünün reseptörüdür. Viral protein ve ACE2 reseptörü arasındaki etkileşim, replikasyon döngüsünde önemli bir adımdır. Bu derlemenin amacı SARS ve MERS ile karşılaştırıldığında COVID-19 akut solunum yolu hastalığına neden olan SARS-CoV-2 virüsünün moleküler yapısı ve genetik özellikleriyle hastalığın klinik etkilerini ortaya koymaktır. COVID-19’un spesifik moleküler detaylarının açıklığa kavuşturulması, tedavi hedeflerine ulaşılmasında yol gösterici olacaktır. Böylelikle COVID-19 için moleküler genetik yöntemlerin geliştirilmesi gelecekte virüse karşı kontrol önlemlerimizi arttıracaktır. 

Anahtar Kelimeler: COVID-19, yeni koronavirüs, ACE2, spike protein
DOI :10.26650/JARHS2020-726533   IUP :10.26650/JARHS2020-726533    Tam Metin (PDF)

Molecular Structure and Genomic Characterization of The New Coronavirus (Covid-19)

Gözde Öztan, Halim İşsever

SARS-CoV-2, transmitted from person to person and associated with the outbreak of atypical pneumonia, first emerged in Wuhan, China. Although bats, SARS-CoV and MERS-CoV are the primary reservoirs for COVID-19, it turns out that SARS-CoV may have been transmitted from the civet in China, MERS-CoV from camels in the Middle East, and COVID-19 from the bat to humans via the pangolin (scaly anteater). SARS-CoV, MERS-CoV and SARS-CoV-2 are coronaviruses belonging to the Coronaviridae family and Betacoronavirus genus, which cause epidemiological outbreaks, are enveloped viruses with approximately 32 Kb long positive sense, ssRNA, and play a role in the pathogenesis of proinflammatory responses with high mortality rates associated with infection. The 2019-nCoV genome has 89% nucleotide identity with bat SARS-like CoVZXC21 and 82% with human SARS-CoV. ACE2 is the receptor of this severe acute respiratory syndrome coronavirus. The aim of this review is to reveal the molecular structure and genetic features of the SARS-CoV-2 virus and the clinical effects of the disease, which causes COVID-19 acute respiratory disease, and to compare it to SARS and MERS. Clarifying the specific molecular details of COVID-19 will guide researchers to the discovery of its treatment. Thus, the development of the molecular genetic methods for COVID-19 will increase our control measures against the virus in the future.

Anahtar Kelimeler: COVID-19, novel coronavirus, ACE2, spike protein

PDF Görünüm

Referanslar

  • 1. Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020;47(5):1275-280. google scholar
  • 2. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(7798):270-73. google scholar
  • 3. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020;63(3):364-74. google scholar
  • 4. Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014;12(5):422-8. google scholar
  • 5. Sutton TC, Subbarao K. Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus. Virology 2015;479480:247-58. google scholar
  • 6. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019; J Clin Invest 2020; 130(5):2620-9. doi: 10.1172/ JCI137244. google scholar
  • 7. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr 2020;87(4):281–6. google scholar
  • 8. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol 2020;1–9. doi: 10.1002/jmv.25748. google scholar
  • 9. Huentelman MJ, Zubcevic J, Hernández Prada JA, Xiao X, Dimitrov DS, Raizada MK, et al. Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor. Hypertension 2004;44(6):903-6. google scholar
  • 10. Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J Microbiol Immunol Infect 2020; doi.org/10.1016/j. jmii.2020.03.022. (Epub ahead of print) google scholar
  • 11. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARSCoV-2 by full-length human ACE2. Science 2020;367(6485):1444-8. google scholar
  • 12. Weiss SR, Leibowitz JL. Coronavirus Pathogenesis. Adv Virus Res 2011;81:85-164. doi: 10.1016/B978-0-12-385885-6.00009-2 google scholar
  • 13. Lissenberg A, Vrolijk MM, van Vliet AL, Langereis MA, de Groot-Mijnes JD, Rottier PJ, et al. Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hem agglutinin esterase protein display reduced fitness in vitro. J Virol 2005;79:15054-63. google scholar
  • 14. Graham RL, Baric RS. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol 2010; 84 (7):3134-46. google scholar
  • 15. de Haan CA, de Wit M, Kuo L, Montalto-Morrison C, Haagmans BL, Weiss SR, et al. The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology 2003;312(2): 395-406. google scholar
  • 16. Ruch TR and Machamer CE. The Coronavirus E Protein: Assembly and Beyond. Viruses 2012;4(3):363-82. google scholar
  • 17. Escors D, Ortego J, Enjuanes L. The membrane M protein of the transmissible gastroenteritis coronavirus binds to the internal core through the carboxyterminus. Adv Exp Med Biol 2001; 494: 589-93. google scholar
  • 18. Khailany AR, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep 2020: 1-6.doi: 10.1016/j.genrep.2020.100682 google scholar
  • 19. Wang H, Li X, Li T, Zhang S, Wang L, Wu X, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis 2020; 24: 1–7. doi: 10.1007/s10096-020-038994 [Epub ahead of print] google scholar
  • 20. Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem and Biophys Res Commun 2020; 525(1):135-40. google scholar
  • 21. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395(10224):565-74. google scholar
  • 22. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25(3): doi: 10.2807/15607917.ES.2020.25.3.2000045. google scholar
  • 23. Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH, et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens. J Clin Microbiol 2020;23:58(5) : doi: 10.1128/ JCM.00310-20. google scholar
  • 24. Tahamtana A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn 2020 May;20(5):453-454. doi: 10.1080/14737159.2020.1757437. google scholar
  • 25. Xiao TA, Tong XY, Zhang S. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients. Clin Infec Dis. 2020; doı: 10.1093/cid/ciaa460. google scholar
  • 26. Pfefferle S, Reucher S, Nörz D, Lütgehetmann M. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS CoV-2 using a high throughput system. Euro Surveill 2020;25(9):200152. doi: 10.2807/15607917.ES.2020.25.9.2000152 google scholar
  • 27. Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020;79:104212. doi: 10.1016/j.meegid.2020.104212. google scholar
  • 28. Licastro D, Rajasekharan S, Dal Monego S, Segat L, D’Agaro P, Marcello A, et al. Isolation and fulllength genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy. J Virol 2020; doi: 10.1128/JVI.00543-20. google scholar
  • 29. Cleemput S, Dumon W, Fonseca V, Karim WA, Giovanetti M, Alcantara LC, et al. Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes. Bioinformatics 2020; doi: 10.1093/bioinformatics/btaa145. google scholar
  • 30. Zhong L, Chuan J, Gong BO, Shuai P, Zhou Y, Zhang Y, et al. Detection of serum IgM and IgG for COVID-19 diagnosis. Sci China Life Sci 2020;25 :1–4. doi: 10.1007/s11427-020-1688-9. (Epub ahead of print) google scholar
  • 31. Guo L, Ren L, Yang S, Xiao M, Chang, Yang F, et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis 2020;21: doi: 10.1093/cid/ciaa310. google scholar
  • 32. Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med 2020;1-10.doi: 10.1007/s11684-020-0767-8. (Epub ahead of print) google scholar
  • 33. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020;28: doi: 10.1093/cid/ciaa344. google scholar
  • 34. Xiang F, Wang X, He X, Peng Z, Yang B, Zhang J, et al. Antibody Detection and Dynamic Characteristics in Patients with COVID-19. Clin Infect Dis 2020; 19: doi: 10.1093/cid/ciaa461. google scholar
  • 35. Wu D, Wu T, Liu Q, Yang Z. The SARSCoV-2 outbreak: What we know. Int J Infect Dis 2020;94:44-8. doi: 10.1016/j. ijid.2020.03.004. (Epub ahead of print) google scholar
  • 36. Chen J. Pathogenicity and transmissibility of 2019-nCoVdA quick overview and comparison with other emerging viruses. Microbes Infect 2020; 22(2):69-71. google scholar
  • 37. Li G ve De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020;19(3):149-50. 38. Lake MA.What we know so far: COVID-19 current clinical knowledge and research.Clinical Medicine 2020; 20(2):124-7. google scholar
  • 39. Meethal ME, Ollakkott S, Varma GG. COVID-19 and SARS-CoV-2: Molecular Genetics Perspectives. Indian J Nat Sci 2020; 59(10):18751-18757. google scholar
  • 40. South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol 2020;318(5): doi: 10.1152/ajpheart.00217.2020. google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Öztan, G., & İşsever, H. (2020). Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 3(2), 61-71. https://doi.org/10.26650/JARHS2020-726533


AMA

Öztan G, İşsever H. Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu. Sağlık Bilimlerinde İleri Araştırmalar Dergisi. 2020;3(2):61-71. https://doi.org/10.26650/JARHS2020-726533


ABNT

Öztan, G.; İşsever, H. Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, [Publisher Location], v. 3, n. 2, p. 61-71, 2020.


Chicago: Author-Date Style

Öztan, Gözde, and Halim İşsever. 2020. “Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi 3, no. 2: 61-71. https://doi.org/10.26650/JARHS2020-726533


Chicago: Humanities Style

Öztan, Gözde, and Halim İşsever. “Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi 3, no. 2 (Nov. 2024): 61-71. https://doi.org/10.26650/JARHS2020-726533


Harvard: Australian Style

Öztan, G & İşsever, H 2020, 'Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu', Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol. 3, no. 2, pp. 61-71, viewed 15 Nov. 2024, https://doi.org/10.26650/JARHS2020-726533


Harvard: Author-Date Style

Öztan, G. and İşsever, H. (2020) ‘Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu’, Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 3(2), pp. 61-71. https://doi.org/10.26650/JARHS2020-726533 (15 Nov. 2024).


MLA

Öztan, Gözde, and Halim İşsever. “Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol. 3, no. 2, 2020, pp. 61-71. [Database Container], https://doi.org/10.26650/JARHS2020-726533


Vancouver

Öztan G, İşsever H. Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu. Sağlık Bilimlerinde İleri Araştırmalar Dergisi [Internet]. 15 Nov. 2024 [cited 15 Nov. 2024];3(2):61-71. Available from: https://doi.org/10.26650/JARHS2020-726533 doi: 10.26650/JARHS2020-726533


ISNAD

Öztan, Gözde - İşsever, Halim. “Yeni Koronavirüsün (Covid-19) Moleküler Yapısı ve Genomik Karakterizasyonu”. Sağlık Bilimlerinde İleri Araştırmalar Dergisi 3/2 (Nov. 2024): 61-71. https://doi.org/10.26650/JARHS2020-726533



ZAMAN ÇİZELGESİ


Gönderim24.05.2020
Kabul24.06.2020
Çevrimiçi Yayınlanma10.07.2020

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.